Imelda Mercado‐Uribe

3.6k total citations
28 papers, 2.2k citations indexed

About

Imelda Mercado‐Uribe is a scholar working on Oncology, Cancer Research and Cell Biology. According to data from OpenAlex, Imelda Mercado‐Uribe has authored 28 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Cancer Research and 9 papers in Cell Biology. Recurrent topics in Imelda Mercado‐Uribe's work include Cancer Cells and Metastasis (8 papers), Microtubule and mitosis dynamics (6 papers) and Cancer Genomics and Diagnostics (5 papers). Imelda Mercado‐Uribe is often cited by papers focused on Cancer Cells and Metastasis (8 papers), Microtubule and mitosis dynamics (6 papers) and Cancer Genomics and Diagnostics (5 papers). Imelda Mercado‐Uribe collaborates with scholars based in United States, China and Taiwan. Imelda Mercado‐Uribe's co-authors include Jinsong Liu, Gong Yang, Daniel Rosen, Shiwu Zhang, Robert C. Bast, Na Niu, Jinyun Liu, Gordon B. Mills, Xiaoqing Guo and Justin A. Colacino and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Imelda Mercado‐Uribe

28 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Imelda Mercado‐Uribe United States 24 1.2k 922 756 421 354 28 2.2k
Daniela Califano Italy 29 1.6k 1.3× 964 1.0× 577 0.8× 258 0.6× 244 0.7× 62 2.6k
Susan Mason United Kingdom 17 1.4k 1.2× 648 0.7× 673 0.9× 202 0.5× 356 1.0× 33 2.1k
Armelle A. Troussard Canada 16 1.7k 1.4× 545 0.6× 488 0.6× 596 1.4× 283 0.8× 19 2.7k
Aya Kobayashi Japan 18 1.3k 1.1× 1.2k 1.3× 536 0.7× 210 0.5× 391 1.1× 46 2.5k
Sharmila A. Bapat India 20 1.6k 1.4× 1.5k 1.6× 741 1.0× 232 0.6× 207 0.6× 53 2.5k
Peter Horak Germany 20 1.2k 1.0× 457 0.5× 590 0.8× 188 0.4× 235 0.7× 68 1.9k
Lin Pei United States 24 1.3k 1.1× 488 0.5× 478 0.6× 226 0.5× 396 1.1× 48 2.6k
Adam J. Krieg United States 23 1.2k 1.0× 486 0.5× 651 0.9× 98 0.2× 452 1.3× 36 2.0k
Brian F. Clem United States 25 2.0k 1.7× 594 0.6× 1.6k 2.1× 180 0.4× 251 0.7× 52 2.8k
Olga Aprelikova United States 30 2.8k 2.3× 1.0k 1.1× 1.1k 1.5× 275 0.7× 270 0.8× 48 3.7k

Countries citing papers authored by Imelda Mercado‐Uribe

Since Specialization
Citations

This map shows the geographic impact of Imelda Mercado‐Uribe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imelda Mercado‐Uribe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imelda Mercado‐Uribe more than expected).

Fields of papers citing papers by Imelda Mercado‐Uribe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Imelda Mercado‐Uribe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imelda Mercado‐Uribe. The network helps show where Imelda Mercado‐Uribe may publish in the future.

Co-authorship network of co-authors of Imelda Mercado‐Uribe

This figure shows the co-authorship network connecting the top 25 collaborators of Imelda Mercado‐Uribe. A scholar is included among the top collaborators of Imelda Mercado‐Uribe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Imelda Mercado‐Uribe. Imelda Mercado‐Uribe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niu, Na, Imelda Mercado‐Uribe, & Jinyun Liu. (2017). Dedifferentiation into blastomere-like cancer stem cells via formation of polyploid giant cancer cells. Oncogene. 36(34). 4887–4900. 191 indexed citations
3.
Zhang, Shiwu, Imelda Mercado‐Uribe, Anil K. Sood, Robert C. Bast, & Jinsong Liu. (2016). Coevolution of neoplastic epithelial cells and multilineage stroma via polyploid giant cells during immortalization and transformation of mullerian epithelial cells. Genes & Cancer. 7(3-4). 60–72. 35 indexed citations
4.
Zhang, Shiwu, Imelda Mercado‐Uribe, & Jinsong Liu. (2013). Tumor stroma and differentiated cancer cells can be originated directly from polyploid giant cancer cells induced by paclitaxel. International Journal of Cancer. 134(3). 508–518. 92 indexed citations
5.
Huang, Jianfei, Jing Zhang, Hongxia Li, et al.. (2013). VCAM1 expression correlated with tumorigenesis and poor prognosis in high grade serous ovarian cancer.. PubMed. 5(3). 336–46. 51 indexed citations
6.
Zhang, Shiwu, Imelda Mercado‐Uribe, & Jinsong Liu. (2013). Generation of erythroid cells from fibroblasts and cancer cells in vitro and in vivo. Cancer Letters. 333(2). 205–212. 65 indexed citations
7.
Shan, Weiwei, Imelda Mercado‐Uribe, Jing Zhang, et al.. (2012). Mucinous adenocarcinoma developed from human fallopian tube epithelial cells through defined genetic modifications. Cell Cycle. 11(11). 2107–2113. 35 indexed citations
8.
Zhang, Jing, et al.. (2012). Sex-determining region Y-box 2 expression predicts poor prognosis in human ovarian carcinoma. Human Pathology. 43(9). 1405–1412. 54 indexed citations
9.
Jia, Lizhou, Shiwu Zhang, Yanfen Ye, et al.. (2012). Paclitaxel inhibits ovarian tumor growth by inducing epithelial cancer cells to benign fibroblast-like cells. Cancer Letters. 326(2). 176–182. 42 indexed citations
10.
Yang, Gong, Xue Xiao, Daniel Rosen, et al.. (2011). The Biphasic Role of NF-κB in Progression and Chemoresistance of Ovarian Cancer. Clinical Cancer Research. 17(8). 2181–2194. 66 indexed citations
11.
Zhang, Jing, et al.. (2011). CD133 expression associated with poor prognosis in ovarian cancer. Modern Pathology. 25(3). 456–464. 112 indexed citations
12.
Guo, Xiaoqing, Guangzhi Liu, Isaiah G. Schauer, et al.. (2011). Overexpression of the β Subunit of Human Chorionic Gonadotropin Promotes the Transformation of Human Ovarian Epithelial Cells and Ovarian Tumorigenesis. American Journal Of Pathology. 179(3). 1385–1393. 26 indexed citations
13.
Yang, Gong, Daniel Rosen, Guangzhi Liu, et al.. (2010). CXCR2 Promotes Ovarian Cancer Growth through Dysregulated Cell Cycle, Diminished Apoptosis, and Enhanced Angiogenesis. Clinical Cancer Research. 16(15). 3875–3886. 150 indexed citations
14.
Yang, Gong, Bin Chang, Fan Yang, et al.. (2010). Aurora Kinase A Promotes Ovarian Tumorigenesis through Dysregulation of the Cell Cycle and Suppression of BRCA2. Clinical Cancer Research. 16(12). 3171–3181. 111 indexed citations
15.
Mercado‐Uribe, Imelda, Daniel Rosen, Bin Chang, et al.. (2010). Induction of papillary carcinoma in human ovarian surface epithelial cells using combined genetic elements and peritoneal microenvironment. Cell Cycle. 9(1). 140–146. 12 indexed citations
16.
Chang, Bin, Guangzhi Liu, Gong Yang, et al.. (2009). REDD1 is required for RAS-mediated transformation of human ovarian epithelial cells. Cell Cycle. 8(5). 780–786. 45 indexed citations
17.
Rosen, Daniel, Imelda Mercado‐Uribe, Gong Yang, et al.. (2006). The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis. Cancer. 107(11). 2730–2740. 109 indexed citations
18.
Yang, Guang, Daniel Rosen, Imelda Mercado‐Uribe, et al.. (2006). Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells. Carcinogenesis. 28(1). 174–182. 59 indexed citations
19.
Yang, Gong, Daniel Rosen, Justin A. Colacino, Imelda Mercado‐Uribe, & Jinyun Liu. (2006). Disruption of the retinoblastoma pathway by small interfering RNA and ectopic expression of the catalytic subunit of telomerase lead to immortalization of human ovarian surface epithelial cells. Oncogene. 26(10). 1492–1498. 16 indexed citations
20.
Yang, Gong, Daniel Rosen, Zhihong Zhang, et al.. (2006). The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. Proceedings of the National Academy of Sciences. 103(44). 16472–16477. 267 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026